Social media has become a primary source of health information for millions of people. Platforms once used mainly for entertainment or social connection now shape opinions about fitness, mental health, diet, and increasingly, medication.

A new scientific review has raised fresh concerns about this shift worldwide, warning that social media influencers who promote prescription drugs or medication are often sharing information that is incomplete, misleading, or difficult for audiences to evaluate critically.

The review, published in JAMA Network Open, examined existing research on how influencers affect public understanding and attitudes towards prescription medications. Its findings suggest that current rules governing pharmaceutical advertising have not kept pace with the fast-moving world of social media. As a result, promotional content can appear informal, personal, and trustworthy, while quietly serving commercial interests.

“Regulatory oversight appeared inconsistent or outdated. Disclosure of sponsorships was often unclear. Medical information was frequently simplified or distorted, particularly when influencers lacked formal scientific and clinical training”

Influencers occupy a unique position in the modern media ecosystem. They build large followings by sharing fragments of daily life, health journeys, struggles, and successes. When prescription drugs appear within these narratives, the distinction between personal experience and paid promotion often becomes blurred. For many viewers, this makes it harder to recognise when they are being marketed to.

The researchers behind the review analysed data from 12 peer‑reviewed studies covering many topics such as contraceptive advertising, performance‑enhancing substances, and broader pharmaceutical marketing online. Despite differences in focus, the studies pointed towards the same patterns. Regulatory oversight appeared inconsistent or outdated. Disclosure of sponsorships was often unclear. Medical information was frequently simplified or distorted, particularly when influencers lacked formal scientific and clinical training.

One recurring concern was the way promotional messages were embedded in emotionally engaging personal stories. When influencers describe their own symptoms, diagnoses, or treatment journeys, audiences tend to respond with empathy and trust. This emotional connection can reduce scepticism, especially when viewers see the influencer as relatable or authentic. In such cases, advertising messages can feel more like friendly advice than marketing.

The review highlights the rise of so‑called patient influencers. These individuals often share lived experiences of illness or treatment and may partner with pharmaceutical companies to discuss specific medications. While such accounts can offer comfort and reduce feelings of isolation, they also carry risks. Personal testimony may be mistaken for medical evidence. Benefits may be over-exaggerated, while side effects or alternative treatments receive little mention.

“Influencer promotion can increase demand for specific medications. It may also encourage inappropriate use or prompt patients to pressure clinicians for prescriptions that are not medically indicated. In some cases, this could contribute to harmful drug interactions or misuse”

Health communication experts note that this dynamic becomes more problematic when audiences have limited health literacy. Without a strong understanding of how prescription drugs work, viewers may struggle to evaluate claims, assess risks, or recognise bias. When combined with subtle marketing techniques, the potential for misunderstanding grows.

The issue is not limited to influencers without medical backgrounds. The review also points to concerns when healthcare professionals participate in influencer marketing. Online content created by clinicians can look similar to professional advice, even when it is sponsored. This resemblance may reduce the caution that people usually apply to traditional pharmaceutical advertising, such as television commercials or printed adverts.

From a public health perspective, the implications are significant. Influencer promotion can increase demand for specific medications. It may also encourage inappropriate use or prompt patients to pressure clinicians for prescriptions that are not medically indicated. In some cases, this could contribute to harmful drug interactions or misuse.

The review describes these relationships as parasocial. Viewers feel as though they know the influencer personally, despite the interaction being one‑sided. This sense of familiarity can make people more receptive to recommendations and less likely to question motives. When sponsorship disclosures are vague or hidden among hashtags, recognising promotional intent becomes even harder.

Researchers emphasise that the evidence base in this area remains relatively small and fragmented. Social media platforms evolve quickly, while academic research and regulatory processes move more slowly. Even so, the consistency of findings across multiple studies suggests a clear need for action.

“Another recommendation focuses on digital health literacy. Teaching people how to evaluate online health information, recognise conflicts of interest, and question persuasive narratives could reduce the impact of misinformation”

The authors call for updated regulatory guidance that reflects how pharmaceutical marketing now operates online. They argue for enforceable and standardised disclosure rules that are easy for users to recognise and understand. Clear labelling of sponsored content could help audiences distinguish between personal opinion and paid promotion.

Another recommendation focuses on digital health literacy. Teaching people how to evaluate online health information, recognise conflicts of interest, and question persuasive narratives could reduce the impact of misinformation. Such initiatives would need to target diverse age groups, as both younger and older users increasingly rely on social media for health guidance.

Platform accountability also features prominently in the review’s conclusions. Social media companies play a central role in shaping what users see. Algorithms that prioritise engagement may inadvertently amplify emotionally charged or sensational content, including misleading health claims. Stronger moderation policies and clearer advertising standards could help limit harm.

“Before making decisions based on information seen on social media, experts recommend consulting qualified healthcare professionals. Doctors and pharmacists can provide evidence‑based guidance, discuss alternatives, and explain potential side effects”

Users are advised to consider an influencer’s training, credentials, and potential conflicts of interest before accepting medical advice. Sponsorships or partnerships with pharmaceutical companies should be disclosed clearly and prominently, not buried in small print.

Even when influencers have medical qualifications, experts stress that online content cannot replace personalised clinical advice. Social media posts are designed for broad appeal, not individual assessment. They rarely account for a person’s medical history, other medications, or unique risk factors. Most of the time, safety guardrails or editorial policies are not in place when producing content, so the content may be misleading or contain biases that the medical influencers themselves do not even realise.

The review also acknowledges that social media can offer genuine benefits. Online communities may provide support, reduce stigma, and encourage people to seek professional help. Hearing about others’ experiences can help individuals articulate symptoms or ask informed questions during medical appointments. Problems arise when these benefits are overshadowed by undisclosed marketing or oversimplified messages.

Researchers urge audiences to be cautious whenever prescription drugs or even supplements are promoted online. This caution should apply regardless of whether a sponsorship is disclosed. Warning signs include content that focuses heavily on benefits, minimises risks, or presents a medication as a quick fix. Emotional storytelling that leads directly to product recommendations deserves particular scrutiny.

Before making decisions based on information seen on social media, experts recommend consulting qualified healthcare professionals. Doctors and pharmacists can provide evidence‑based guidance, discuss alternatives, and explain potential side effects. They can also help patients contextualise what they have seen online.

Clinicians themselves are encouraged to invite open conversation. Patients may hesitate to mention social media influences for fear of being judged. Creating a non‑judgemental space allows healthcare providers to address misinformation and build trust. This dialogue can strengthen the therapeutic relationship and improve safety.

“Health experts advise turning first to official government websites and well‑established health information and evidenced-based health news or media when seeking medical and health guidance”

The review’s findings arrive at a time when digital advertising frameworks are under growing strain. Traditional pharmaceutical marketing has long been subject to strict rules about risk disclosure and balance. Online influencer content often falls into regulatory grey areas, especially when it is framed as personal storytelling rather than direct advertising.

Experts argue that refining these frameworks is essential for maintaining public trust. Transparent disclosure, balanced information about risks and benefits, and clear separation between advertising and advice are key principles. Applying them consistently across digital platforms remains a challenge.

As social media continues to shape health conversations, the role of influencers in promoting prescription drugs is likely to expand. This makes the need for updated oversight more urgent. Without it, audiences may continue to receive messages that are persuasive but not fully accurate.

The review does not call for banning influencer involvement altogether. Instead, it highlights the need for safeguards that protect users while allowing meaningful sharing of experiences. Responsible communication, supported by clear rules and informed audiences, could help strike this balance.

Health experts advise turning first to official government websites and well‑established health information and evidenced-based health news when seeking medical and health guidance. Using these trusted sources can help people avoid misinformation, understand both benefits and risks, and make informed decisions about their health with greater confidence.

In the meantime, viewers are urged to approach online health content with curiosity and caution. Personal stories can be powerful, but they are not substitutes for scientific evidence. In a crowded digital landscape, critical thinking remains one of the most effective tools for navigating health information safely.